Fosun Pharma executes share buyback on HKEX and Shanghai

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKEX: 2196) announced a share buyback executed on April 30, 2025, across both the Hong Kong Stock Exchange (HKEX) and the Shanghai Stock Exchange. On the HKEX, the company repurchased 709,500 H shares at prices ranging from HKD 13.94 to HKD 14.3, with a total expenditure of HKD 9,969,830. Simultaneously, on the Shanghai Stock Exchange, Fosun Pharma repurchased 1,298,000 A shares, spending RMB 30,396,489, with prices ranging from RMB 23.34 to RMB 23.54 per share. The company confirmed that the buybacks comply with Main Board Rules. Following the repurchase, the total number of treasury shares stands at 12,988,252 A shares and 9,923,500 H shares.